Novavax - 26 Year Stock Price History | NVAX

Historical daily share price chart and data for Novavax since 1995 adjusted for splits. The latest closing stock price for Novavax as of September 16, 2021 is 237.27.
  • The all-time high Novavax stock closing price was 319.93 on February 08, 2021.
  • The Novavax 52-week high stock price is 331.68, which is 39.8% above the current share price.
  • The Novavax 52-week low stock price is 76.59, which is 67.7% below the current share price.
  • The average Novavax stock price for the last 52 weeks is 172.52.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Novavax Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 199.5762 112.9800 319.9300 112.9800 237.2700 112.78%
2020 69.3011 4.4900 178.5100 3.9300 111.5100 2701.76%
2019 12.1012 39.4000 46.8000 3.6900 3.9800 -89.18%
2018 35.1765 26.0000 49.6000 23.4000 36.8000 48.39%
2017 23.4596 25.4000 32.6000 14.6800 24.8000 -1.59%
2016 95.1524 157.6000 166.8000 23.6000 25.2000 -84.98%
2015 179.2758 115.2000 282.8000 114.8000 167.8000 41.48%
2014 98.5063 104.2000 133.0000 73.8000 118.6000 15.82%
2013 52.5332 39.4000 103.2000 35.0000 102.4000 170.90%
2012 33.0187 27.6000 47.8000 23.2000 37.8000 50.00%
2011 39.4103 51.4000 59.2000 23.6000 25.2000 -48.15%
2010 47.0562 56.2000 60.4000 40.2000 48.6000 -8.65%
2009 56.0539 40.4000 133.0000 11.2000 53.2000 40.74%
2008 51.5972 65.2000 70.6000 27.6000 37.8000 -43.24%
2007 67.2954 77.4000 90.0000 51.8000 66.6000 -18.78%
2006 93.8374 77.6000 166.2000 56.8000 82.0000 6.49%
2005 42.3058 64.8000 110.6000 14.8000 77.0000 18.10%
2004 92.4413 120.2000 138.4000 58.6000 65.2000 -45.67%
2003 102.6408 56.0000 164.4200 52.7800 120.0000 130.77%
2002 120.5912 272.4000 272.4000 37.2000 52.0000 -81.56%
2001 213.7363 168.2000 300.6000 138.8000 282.0000 65.88%
2000 152.4373 115.0000 231.2000 95.0000 170.0000 51.25%
1999 77.3056 40.0000 118.8000 38.8000 112.4000 189.69%
1998 66.5198 101.2000 116.2000 27.6000 38.8000 -61.20%
1997 87.7589 67.6000 115.0000 60.0000 100.0000 45.35%
1996 98.8654 80.0000 162.4000 60.0000 68.8000 -8.27%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.303B $0.476B
NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $175.368B 54.17
Bristol Myers Squibb (BMY) United States $137.771B 9.17
Amgen (AMGN) United States $123.866B 13.41
CSL (CSLLY) Australia $102.597B 0.00
Gilead Sciences (GILD) United States $89.973B 8.70
BioNTech SE (BNTX) Germany $86.154B 18.59
Regeneron Pharmaceuticals (REGN) United States $69.735B 11.97
Illumina (ILMN) United States $65.997B 74.98
Vertex Pharmaceuticals (VRTX) United States $48.996B 19.04
Biogen (BIIB) United States $44.592B 12.24
BeiGene (BGNE) Cayman Islands $34.845B 0.00
Genmab (GMAB) Denmark $28.151B 69.13
Seagen (SGEN) United States $27.670B 46.65
Genmab (GNMSF) Denmark $27.591B 68.97
Horizon Therapeutics Public (HZNP) Ireland $23.961B 22.71
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.282B 0.00
Bio-Techne Corp (TECH) United States $20.698B 93.08
Exact Sciences (EXAS) United States $17.994B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.550B 0.00
Repligen (RGEN) United States $16.274B 124.02
Incyte (INCY) United States $16.218B 38.45
BioMarin Pharmaceutical (BMRN) United States $14.168B 101.67
Guardant Health (GH) United States $12.865B 0.00
QIAGEN (QGEN) Netherlands $12.195B 20.65
Zai Lab (ZLAB) China $11.901B 0.00
Intellia Therapeutics (NTLA) United States $11.055B 0.00
CureVac (CVAC) Germany $10.540B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.935B 22.95
Biohaven Pharmaceutical Holding (BHVN) United States $8.894B 0.00
Ascendis Pharma (ASND) Denmark $8.873B 0.00
Mirati Therapeutics (MRTX) United States $8.677B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.170B 0.00
Vir Biotechnology (VIR) United States $6.832B 0.00
Beam Therapeutics (BEAM) United States $6.775B 0.00
Sarepta Therapeutics (SRPT) United States $6.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.580B 0.00
Exelixis (EXEL) United States $6.449B 70.59
Denali Therapeutics (DNLI) United States $6.402B 181.48
Fate Therapeutics (FATE) United States $6.330B 0.00
Blueprint Medicines (BPMC) United States $6.076B 17.15
Halozyme Therapeutics (HALO) United States $5.871B 23.98
Legend Biotech (LEGN) United States $5.871B 0.00
NeoGenomics (NEO) United States $5.802B 786.33
Twist Bioscience (TWST) United States $5.568B 0.00
Certara (CERT) United States $5.524B 0.00
I-Mab (IMAB) China $5.243B 0.00
AbCellera Biologics (ABCL) $5.242B 0.00
Adaptive Biotechnologies (ADPT) United States $5.153B 0.00
Alkermes (ALKS) Ireland $4.951B 146.14
Arvinas (ARVN) United States $4.668B 0.00
Editas Medicine (EDIT) United States $4.116B 0.00
Reata Pharmaceuticals (RETA) United States $3.859B 0.00
Galapagos (GLPG) Belgium $3.634B 0.00
Arena Pharmaceuticals (ARNA) United States $3.609B 0.00
SpringWorks Therapeutics (SWTX) United States $3.544B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Kymera Therapeutics (KYMR) United States $3.317B 0.00
Prothena (PRTA) Ireland $3.305B 0.00
Insmed (INSM) United States $3.185B 0.00
ALX Oncology Holdings (ALXO) United States $3.154B 0.00
Emergent Biosolutions (EBS) United States $3.069B 7.40
Amicus Therapeutics (FOLD) United States $2.969B 0.00
Apellis Pharmaceuticals (APLS) United States $2.951B 0.00
Cytokinetics (CYTK) United States $2.814B 0.00
Intra-Cellular Therapies (ITCI) United States $2.723B 0.00
Heska (HSKA) United States $2.701B 517.80
ACADIA Pharmaceuticals (ACAD) United States $2.554B 0.00
Myriad Genetics (MYGN) United States $2.554B 0.00
Seer (SEER) $2.493B 0.00
Instil Bio (TIL) United States $2.476B 0.00
Celldex Therapeutics (CLDX) United States $2.473B 0.00
Morphic Holding (MORF) United States $2.442B 0.00
Arcus Biosciences (RCUS) United States $2.382B 0.00
Vericel (VCEL) United States $2.378B 283.33
Sorrento Therapeutics (SRNE) United States $2.367B 0.00
C4 Therapeutics (CCCC) United States $2.364B 0.00
Ligand Pharmaceuticals (LGND) United States $2.266B 33.14
Protagonist Therapeutics (PTGX) United States $2.210B 0.00
Atea Pharmaceuticals (AVIR) United States $2.151B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.072B 35.29
Amarin (AMRN) Ireland $2.040B 516.00
Myovant Sciences (MYOV) United Kingdom $2.010B 0.00
NGM Biopharmaceuticals (NGM) United States $1.983B 0.00
Alector (ALEC) United States $1.962B 0.00
REGENXBIO (RGNX) United States $1.924B 0.00
Revance Therapeutics (RVNC) United States $1.905B 0.00
Castle Biosciences (CSTL) United States $1.881B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.830B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.802B 0.00
Berkeley Lights (BLI) United States $1.786B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
UniQure (QURE) Netherlands $1.676B 5.70
MorphoSys AG (MOR) Germany $1.671B 0.00
Dynavax Technologies (DVAX) United States $1.662B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.649B 0.00
Global Blood Therapeutics (GBT) United States $1.621B 0.00
Nurix Therapeutics (NRIX) United States $1.616B 0.00
Codexis (CDXS) United States $1.600B 0.00
Inovio Pharmaceuticals (INO) United States $1.592B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.563B 0.00
MaxCyte (MXCT) United States $1.541B 0.00
Zymeworks (ZYME) Canada $1.532B 0.00
Kadmon Holdings (KDMN) United States $1.517B 0.00
Ocugen (OCGN) United States $1.497B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.475B 0.00
Bionano Genomics (BNGO) United States $1.474B 0.00
Travere Therapeutics (TVTX) United States $1.429B 0.00
Genetron Holdings (GTH) China $1.420B 0.00
PureTech Health (PRTC) United States $1.418B 0.00
Zealand Pharma (ZEAL) Denmark $1.398B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.393B 0.00
Scholar Rock Holding (SRRK) United States $1.380B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.377B 0.00
Inhibrx (INBX) United States $1.372B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Agenus (AGEN) United States $1.253B 0.00
BioAtla (BCAB) United States $1.246B 0.00
Coherus BioSciences (CHRS) United States $1.208B 0.00
Bluebird Bio (BLUE) United States $1.203B 0.00
Avid Bioservices (CDMO) United States $1.169B 238.13
MannKind (MNKD) United States $1.166B 0.00
Repare Therapeutics (RPTX) Canada $1.143B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.143B 0.00
Precigen (PGEN) United States $1.130B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.117B 0.00
RAPT THERAPTICS (RAPT) United States $1.105B 0.00
Fulcrum Therapeutics (FULC) United States $1.087B 0.00
Northwest Biotherapeutics (NWBO) United States $1.075B 0.00
ImmunityBio (IBRX) United States $1.046B 0.00
IDEAYA Biosciences (IDYA) United States $1.002B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.983B 0.00
Nkarta (NKTX) United States $0.968B 0.00
Prometheus Biosciences (RXDX) United States $0.949B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.941B 0.00
Sutro Biopharma (STRO) United States $0.922B 0.00
Immatics (IMTX) Germany $0.920B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.909B 28.17
BeyondSpring (BYSI) United States $0.898B 0.00
Avidity Biosciences (RNA) United States $0.862B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Mesoblast (MESO) Australia $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Curis (CRIS) United States $0.765B 0.00
Precision BioSciences (DTIL) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.740B 92.31
Keros Therapeutics (KROS) United States $0.728B 0.00
Amryt Pharma (AMYT) United Kingdom $0.717B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.711B 0.00
AnaptysBio (ANAB) United States $0.709B 0.00
Pliant Therapeutics (PLRX) United States $0.677B 0.00
Adagene (ADAG) China $0.665B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.656B 11.95
Mersana Therapeutics (MRSN) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Cellectis S.A (CLLS) France $0.636B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.633B 0.00
Gritstone Bio (GRTS) United States $0.632B 0.00
Ambrx Biopharma (AMAM) United States $0.629B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
MiMedx (MDXG) United States $0.626B 0.00
Affimed (AFMD) Germany $0.622B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.620B 0.00
Akoya Biosciences (AKYA) United States $0.617B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Spero Therapeutics (SPRO) United States $0.596B 0.00
Bolt Biotherapeutics (BOLT) United States $0.595B 0.00
G1 THERAPEUTICS (GTHX) United States $0.590B 0.00
Seres Therapeutics (MCRB) United States $0.582B 0.00
Anika Therapeutics (ANIK) United States $0.574B 0.00
DBV Technologies S.A (DBVT) France $0.573B 0.00
MeiraGTx Holdings (MGTX) United States $0.569B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
ALBIREO PHARMA (ALBO) United States $0.563B 0.00
Vaccitech (VACC) United Kingdom $0.553B 0.00
Epizyme (EPZM) United States $0.550B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Inventiva S.A (IVA) France $0.522B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.501B 0.00
AC Immune SA (ACIU) Switzerland $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Selecta Biosciences (SELB) United States $0.491B 0.00
Cel-Sci (CVM) United States $0.481B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.480B 0.00
XBiotech (XBIT) United States $0.479B 0.00
Verastem (VSTM) United States $0.461B 0.00
Clene (CLNN) United States $0.457B 0.00
ChromaDex (CDXC) United States $0.455B 0.00
Bellus Health (BLU) Canada $0.454B 0.00
Innate Pharma S.A (IPHA) France $0.442B 0.00
Geron (GERN) United States $0.436B 0.00
Oncobiologics (OTLK) United States $0.424B 0.00
Compugen (CGEN) Israel $0.419B 0.00
Arbutus Biopharma (ABUS) United States $0.418B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.415B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.410B 12.61
Codiak BioSciences (CDAK) United States $0.403B 0.00
SQZ Biotechnologies (SQZ) United States $0.398B 0.00
Clearside Biomedical (CLSD) United States $0.391B 0.00
Starpharma Holdings (SPHRY) Australia $0.390B 0.00
Cue Biopharma (CUE) United States $0.382B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.381B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.371B 0.00
Athenex (ATNX) United States $0.371B 0.00
Cybin (CYBN) Canada $0.368B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 9.54
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
Neoleukin Therapeutics (NLTX) United States $0.341B 0.00
Opthea (OPT) Australia $0.338B 0.00
Fortress Biotech (FBIO) United States $0.335B 0.00
Athersys (ATHX) United States $0.333B 0.00
Prima BioMed (IMMP) Australia $0.327B 0.00
Cogent Biosciences (COGT) United States $0.325B 0.00
Syros Pharmaceuticals (SYRS) United States $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.319B 0.00
INmune Bio (INMB) United States $0.312B 0.00
AquaBounty Technologies (AQB) United States $0.298B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.290B 0.00
Puma Biotechnology (PBYI) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.281B 0.00
XOMA (XOMA) United States $0.275B 115.81
Beyond Air (XAIR) United States $0.272B 0.00
Checkpoint Therapeutics (CKPT) United States $0.262B 0.00
Cardiff Oncology (CRDF) United States $0.259B 0.00
IBio (IBIO) United States $0.244B 0.00
Frequency Therapeutics (FREQ) United States $0.243B 0.00
Kamada (KMDA) Israel $0.239B 19.85
OVID THERAPEUTC (OVID) United States $0.235B 2.06
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
Kaleido Biosciences (KLDO) $0.229B 0.00
Adicet Bio (ACET) United States $0.225B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.224B 0.00
Adverum Biotechnologies (ADVM) United States $0.213B 0.00
Seelos Therapeutics (SEEL) United States $0.203B 0.00
NextCure (NXTC) United States $0.201B 0.00
Trevena (TRVN) United States $0.201B 0.00
Kala Pharmaceuticals (KALA) United States $0.200B 0.00
Talis Biomedical (TLIS) United States $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
SESEN BIO, INC (SESN) United States $0.183B 0.00
TELA Bio (TELA) United States $0.181B 0.00
ObsEva SA (OBSV) Switzerland $0.176B 0.00
CorMedix Inc (CRMD) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
VolitionRX (VNRX) United States $0.170B 0.00
Synlogic (SYBX) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.165B 48.57
TScan Therapeutics (TCRX) United States $0.165B 0.00
HOOKIPA Pharma (HOOK) United States $0.164B 0.00
Aptinyx (APTX) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Galena Biopharma (SLS) United States $0.160B 0.00
ADMA Biologics Inc (ADMA) United States $0.159B 0.00
Catalyst Biosciences (CBIO) United States $0.159B 0.00
Erytech Pharma SA (ERYP) France $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.146B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Biofrontera AG (BFRA) Germany $0.145B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.145B 0.00
ATyr Pharma (LIFE) United States $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 0.00
Nicox SA (NICXF) France $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Novogen (KZIA) Australia $0.135B 0.00
Purple Biotech (PPBT) Israel $0.129B 0.00
Cyclerion Therapeutics (CYCN) United States $0.127B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Evofem Biosciences (EVFM) United States $0.123B 0.00
Eton Pharmaceuticals (ETON) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.122B 248.00
X4 Pharmaceuticals (XFOR) United States $0.119B 0.00
Exicure (XCUR) United States $0.119B 0.00
Yumanity Therapeutics (YMTX) United States $0.118B 0.00
Eyenovia (EYEN) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.115B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Voyager Therapeutics (VYGR) United States $0.114B 6.54
Viridian Therapeutics (VRDN) United States $0.114B 0.00
Entera Bio (ENTX) Israel $0.109B 0.00
Palatin Technologies (PTN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.097B 0.00
Pluristem Therapeutics (PSTI) Israel $0.095B 0.00
Aadi Bioscience (AADI) United States $0.090B 0.00
Celsion (CLSN) United States $0.089B 0.00
Lumos Pharma (LUMO) United States $0.088B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.080B 0.00
Advaxis (ADXS) United States $0.080B 0.00
Liminal BioSciences (LMNL) Canada $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.075B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
DiaMedica Therapeutics (DMAC) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Emmaus Life Sciences (EMMA) United States $0.071B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Longeveron (LGVN) United States $0.070B 0.00
Celyad SA (CYAD) Belgium $0.069B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
AIkido Pharma (AIKI) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Enveric Biosciences (ENVB) United States $0.057B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.08
Genetic Technologies (GENE) Australia $0.052B 0.00
Statera Biopharma (STAB) United States $0.050B 0.00
Vallon Pharmaceuticals (VLON) United States $0.049B 0.00
Forte Biosciences (FBRX) United States $0.049B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
ARIDIS PHARMACT (ARDS) United States $0.048B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Soligenix (SNGX) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Alimera Sciences (ALIM) United States $0.038B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.036B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.031B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00